A multistate trial of pharmacy syringe purchase

Journal of Urban Health

Volumn 81, Issue 4, 2004, Pages 661-670

  Compton, Wilson M ^a,h   Horton, Joe C ^b   Cottler, Linda B ^c   Booth, Robert ^d   Leukefeld, Carl G ^e   Singer, Merrill ^f   Cunningham Williams, Renee ^c   Reich, Wendy ^c   Corsi, Karen Fortuin ^d   Staton, Michele ^e   Fink, Joseph L ^e   Stopka, Thomas J ^g   Spitznagel, Edward L ^c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Entrenar Inc   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f Hispanic Research Council   (United States)

^g CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^h MSC 9589 ^*  (United States)

Author keywords

HIV AIDS prevention; Infection drug use; Pharmacies; Syringe purchase

Indexed keywords

ARTICLE; DRUG ABUSE; GENDER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PHARMACY; PRIORITY JOURNAL; PURCHASING; RACE; RURAL AREA; SYRINGE; UNITED STATES; URBAN AREA;

COMMERCE; FEMALE; HIV INFECTIONS; HUMANS; MALE; PHARMACIES; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS; SYRINGES; UNITED STATES;

EID: 7644244666     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jth149     Document Type: Article

References (32)

1. Richard AJ, Mosier V, Atkinson JS. New syringe acquisition and multi-person use of syringes among illegal drug users. J Public Health Policy. 2002;23:324-343.
2. Friedman SR, Perils T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001;91:791-793.
3. Burris S, ed. Deregulation of Hypodermic Needles and Syringes as a Public Health Measure: a Report on Emerging Policy and Law in the United States. Washington, DC: American Bar Association; 2001.
4. Compton WM, Cottler LB, Decker SH, Mager D, Stringfellow R. Legal needle buying in St. Louis. Am J Public Health. 1992;82:595-596.
5. National Alliance of State and Territorial AIDS Directors. HIV prevention and access to sterile syringes. Joint letter issued by the American Medical Association, American Pharmaceutical Association, Association of State and Territorial Health Officials, National Association of Boards of Pharmacy, National Alliance of State and Territorial AIDS Directors. October 1999. Available at: www.cdc.gov/idu/pubs/hiv_prev_acc.htm. Accessed September 24, 2003.
6. Lundberg GD. New winds blowing for American Drug Policies [editorial]. JAMA. 1997;278:946-947.
7. Lurie P, Reingold AL, Browser B, et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. Prepared for the Centers for Disease Control and Prevention; Berkeley, CA; 1993.
8. Burris S, Welsh J, Ng M, Li M, Ditzler A. State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users. J Am Pharm Assoc. 2002;42(6 suppl 2):S94-S98.
9. Klein SJ, Harris-Valente K, Candelas AR, et al. What do pharmacists think about New York State's new nonprescription syringe sale program? Results of a survey. J Urban Health. 2001;78:679-689.
10. Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002). J Am Pharm Assoc. 2002;42(6 suppl 2):S83-S87.
11. Shotsky WJ, Cooper JG, Klein SJ. As easy as ESAP. The New York State Expanded Syringe Access Demonstration Program. Body Positive. 2003;16:15-17.
12. Kassler W, Ayotte D. Deregulation of syringe sale and possession in New Hampshire, 1991-2000. J Am Pharm Assoc. 2002;42(suppl 2):S21-S22.
13. Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. J AIDS. 2001;27:183-192.
14. Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998;113(suppl 1):81-89.
15. Burris S, Vernick JS, Ditzler A, Strathdee S. The legality of selling or giving syringes to injection drug users. J Am Pharm Assoc. 2002;42(6 suppl 2):S13-S18.
16. Latkin CA, Forman VL. Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, USA. J AIDS. 2001;27:398-404.
17. Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc. 2002;42(6 suppl 2):S77-S82.
18. Reich W, Compton WM, Horton JC, et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc. 2002;42(suppl 2):S68-S72.
19. Case P, Meredith G, Garcia D, et al. Needle exchange: from civil disobedience to public policy. Multicult Inquiries Res AIDS. 1990;4(4):1-3.
20. Stata Inc. Stata Documentation Set. College Station, TX: Stata Press; 2001.
21. Reich W, Compton WM, Horton JC, et al. Pharmacist ambivalence about sale of syringes to injection drug users. J Am Pharm Assoc. 2002;42(suppl 2):S52-S57.
22. Community Epidemiology Work Group. Epidemiological Trends in Drug Abuse-Advance Report. Washington, DC: National Institute on Drug Abuse, 2003. NIH Publication 03-5363.
23. Stopka TJ, Singer M, Teng W, Horton J, Compton WM. Pharmacy access to over-the-counter (OTC) syringes in Connecticut: implications for HIV and hepatitis prevention among injection drug users. AIDS Public Policy J. In press.
24. Coffin PO, Ahern J, Dorris S, Stevenson L, Fuller C, Vlahov D. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J Am Pharm Assoc. 2002;42(6 suppl 2):S62-S67.
25. Jones TS, Coffin PO. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. J Am Pharm Assoc. 2002;42(6 suppl 2):S6-S9.
26. Lewis BA, Koester SK, Bush TW. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc. 2002;42(6 suppl 2): S46-S51.
27. Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc. 2002;42(6 suppl 2):S40-S45.
28. Blumenthal WJ, Springer KW, Jones TS, Sterk CE. Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users. J Am Pharm Assoc. 2002;42(6 suppl 2):S34-S39.
29. Rich JD, Whitlock TL, Towe CW, et al. Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island. Subst Use Misuse. 2001;36(5):535-550.
30. Moatti JP, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res. 2001;7:40-45.
31. Harbke CR, Fisher DG, Cagle HH, Trubatch BN, Fenaughty AM, Johnson ME. Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices. J Urban Health. 2000;77:113-120.
32. Simpson HL. Injection drug users and pharmacists: a call for compassion, cooperation, and care. J Am Pharm Assoc. 2002;42(6 suppl 2):S10-S12.